Select Publications

2022
LaBonte ML. 2022. “Diagnostic uncertainty, microbes, and the isolation of people with cystic fibrosis.” Journal of the History of Medicine and Allied Sciences, 77, 2, Pp. 186-216.
LaBonte M. 2022. “The value of the patient voice: A review of Salt in My Soul by Mallory Smith.” Cambridge Quarterly of Healthcare Ethics.
2021
LaBonte ML. 2021. “Addressing uncertainty: The emergence of the CRMS/CFSPID diagnostic category following newborn screening for cystic fibrosis.” OBM Genetics: Special Issue co-edited by Diane B. Paul and Ilana Löwy on Policy Issues in Prenatal and Neonatal Testing, Counseling, and Decision-Making , 5, 3.
2018
LaBonte ML. 2018. “Book review of The gene: from genetics to postgenomics by Hans-Jörg Rheinberger and Staffan Müller-Wille.” New Genetics and Society.
LaBonte ML. 2018. “The mist tent: An analysis of therapeutic change in the history of cystic fibrosis care.” Bulletin of the History of Medicine, 92, Winter, Pp. 634–663.
2017
LaBonte ML. 2017. “Blobel and Sabatini's "beautiful idea:" Visual representations of the conception and refinement of the signal hypothesis.” Journal of the History of Biology, 50, 4, Pp. 797-833.
2015
LaBonte ML. 2015. “Elements of informed consent for preimplantation genetic diagnosis.” In Transferring the Single Euploid Embryo: Molecular Genetics in Reproductive Medicine, edited by Sills ES, Pp. 5-9. Springer.
Richardson SS, Reiches M, Shattuck-Heidorn H, LaBonte ML, and Consoli T. 2015. “Focus on preclinical sex differences will not address women’s and men’s health disparities.” Proceedings of the National Academy of Sciences, 112, 44, Pp. 13419-13420.
2014
LaBonte ML. 2014. “Anticoagulant factor V: Factors affecting the integration of novel scientific discoveries into the broader framework.” Studies in History and Philosophy of Biological and Biomedical Sciences, 47, Pp. 23-34.